Brief: ImmixBio Initiates IMX-110 GMP Manufacturing Scale-Up
31/01/2022 13:40
Jan 31 (Reuters) - Immix Biopharma Inc IMMX.O :
* IMMIXBIO INITIATES IMX-110 GMP MANUFACTURING SCALE-UP,
POTENTIALLY ACCELERATING CLINICAL TRIAL DATA
Source text for Eikon: ID:nGNX6BVBtb
Further company coverage: IMMX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Immix Biopharma
See all newsBrief: Immix Biopharma Announces Closing Of $125 Million Underwritten Offering Of Common Stock
US RESEARCH ROUNDUP-Alnylam Pharmaceuticals, Carvana, MongoDB
Brief: Immix Biopharma Announces Pricing Of $125 Million Underwritten Offering Of Common Stock
Brief: Immix Biopharma Announces 89% Complete Response Rate At Interim Update Across All Nexicart-2 Patients, With Mrd-Negativity Indicating Potential To Reach Up To 98% Complete Response Rate
Immix Biopharma, Inc. reports results for the quarter ended June 30 - Earnings Summary